AwesomeCapital
Search This Blog
Monday, June 10, 2019
CRISPR Therapeutics started at Buy by Roth
Target $50
https://www.benzinga.com/stock/CRSP/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.